Register today and help us celebrate the 30th Annual Molecular & Precision Med TRI-CON.
Hear featured Keynote, J. Craig Venter, PhD, Founder, Chairman, and CEO, J. Craig Venter Institute
Don't miss the following panel discussion
#TRICON, #Precisionhealth, #Diagnostics
“Synthego’s industry-leading CRISPR-based genome engineering platform was essential in accelerating @QBI_UCSF’s Coronavirus Research,” said Dr. Krogan, a professor at UCSF, Director of QBI when describing new Science publication. https://t.co/7nqGPL3uqD #COVID19@KroganLab
This #syntheticbiology company is providing the picks and axes to help researchers and drug makers find therapeutic gold — and it just raised $100M that could be a precursor to an #IPO#CRISPR#celltherapy#genetherapy@Synthego https://t.co/jXD7ky0OSp
Building the new paradigm for R&D, Synthego is focused on providing unprecedented scale and speed of discovery. In this recent article, Jason Steiner, Synthego's Chief Strategy Officer, discusses the ongoing transformation in life sciences. https://t.co/pc05JuMkpv @bpdealmakers
For my friends in the UK, please check out our documentary on the science revolution known as #CRISPR on the BBC's Storyville. (BBC Four) TOMORROW (January 27) at 9pm. More info here: This might end up being the biggest story I will ever have covered. https://t.co/nWhdCB7YkW
Mark your calendars for the largest #PrecisionMedicine Conference yet. #PMWC20. Santa Clara Convention Ctr, January 21-24. 400 speakers, 5 tracks. Book & Save by July 31. #AI/MachineLearning, #EmergingTherapeutics#Clinical Diagnostics #Genomics https://t.co/lVSCXiJ4jm
SFBN Feed: Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR: Results show potential of MultiTAA therapy in combination with ... #BayArea#Biotech https://t.co/b6bxZzf9vJ
Happy to see all the interest in #neuralink this week, and some thoughtful analysis as well. We still have a long way to go, but it’s been great to see how much happens when a team of world-class people with such different expertise work side-by-side, focused on the same goals.
WSJ mourns the loss of our passionate and gifted colleague Lucette Lagnado, a reporter here for nearly 25 years. Lucette, who reported on the uninsured, the sick and the elderly, wrote with great insight and empathy. Our newsroom and our readers will miss her greatly.